Skip to content Go to the main menu Go to the search form Go to the footer menu
Back to news

Therapeutic adherence at the forefront of the new #BecauseISaySo campaign

Share the article
Therapeutic adherence at the forefront of the new #BecauseISaySo campaign

While awareness is the first step, long-term control depends on what happens after diagnosis. Consistently taking medication, regular follow-up appointments, and healthy lifestyle habits can help patients stay on track and achieve better control over time.

Did you know?

Someone is considered “nonadherent” if they comply with less than 80% of their prescribed treatment plan.1

Across social media  – InstagramFacebookYouTubeLinkedInX, and Threads#BecauseISaySo #TakeControl and #TakeYourMedicine have a strong and consistent campaign presence, amplifying key messages around awareness, action, and long-term health management.

Designed for patients and health care professionals, the campaign uses a range of communication materials, including videos, animated visuals, brochures, and posters to provide practical support and guidance on improving treatment adherence. The message is simple: small daily actions can contribute to meaningful long-term health benefits. #BecauseISaySo #TakeYourMedicine is endorsed by the International Society of Hypertension (ISH) and has been developed in close collaboration with patients.

00:00 / 00:00

Adherence to treatment plans for chronic conditions has become a key issue in the health care sector. As the leading pharmaceutical group in hypertension and sixth in cardiology,3 we firmly believe that treatment adherence is key to treating patients and improving their care. Resolving the adherence issue constitutes an unmet medical need,4 and this is why Servier places particular emphasis on 3 key areas:

  • Therapeutic information, which raises awareness and educates patients and health care professionals through close collaboration with international experts, learned societies, and patient organizations. The aim is to empower patients to take an active role in their treatment by helping them to better understand their disease and treatment options. Find out more about training for health care professionals.
  • Single-pill combinations (SPCs), which combine several molecules in a single tablet to simplify treatment and make it easier for patients to take their medication every day. Learn more about single-pill combinations.
  • Beyond-the-pill digital innovation, which uses applications as “digital companions” to support patient health.

Learn more about Servier’s commitment to cardiovascular diseases

Learn more about Servier’s commitment to cardiovascular diseases

[1] Mosnier-Pudar H. Med Mal Metab. 2012;6(1):66-71. https://www.sciencedirect.com/science/article/abs/pii/S1957255712703577
[2] Médecine des Maladies Métaboliques, 2012, https://www.sciencedirect.com/science/article/abs/pii/S1957255712703577
[3] IQVIA, Analytics Link / World 84 countries – MAT Q1-2026
[4] Cardiovascular UMN blog, efpia.eu